Try our Advanced Search for more refined results
Humana Inc.
-
Response | Filed: January 30, 2023 | Entered: January 30, 2023 In Re: Zetia (Ezetimibe) Antitrust Litigation
Anti-Trust | Virginia Eastern
Memorandum in Opposition
Memorandum in Opposition re 1861 MOTION in Limine No. 24 to Exclude Statements Suggesting that the Glenmark and Mylan Cases Would Have Been Evaluated Differently at the Time of the Glenmark Settlement (on behalf of Merck and Glenmark Defendants) Memorandum in Opposition filed on behalf of Purchasers filed by AmerisourceBergen Corporation, AmerisourceBergen Drug Corporation, CESAR CASTILLO, INC., individually and on behalf of all those similarly situated, Cardinal Health P.R. 120, Inc., Cardinal Health, Inc., FWK Holdings, LLC, H.D. Smith, LLC, KPH Healthcare Services, Inc., MLI RX, LLC, McKesson Corporation, Meijer Distribution, Inc., Meijer, Inc., Rochester Drug Cooperative, Inc., on behalf of itself and all others similarly situated, SUPERVALU, Inc., Smith Medical Partners, LLC, The Harvard Drug Group, L.L.C., Valley Wholesale Drug Company, LLC, Wegmans Food Markets, Inc.. (Monroe, William)
-
Response | Filed: January 30, 2023 | Entered: January 30, 2023 In Re: Zetia (Ezetimibe) Antitrust Litigation
Anti-Trust | Virginia Eastern
Memorandum in Opposition
Memorandum in Opposition re 1858 MOTION in Limine No. 23 to Preclude Dr. McGuire from Testifying Regarding the Amount of Monetary Harm or Damages Suffered by Zetia Purchasers (on behalf of Merck and Glenmark Defendants) Memorandum in Opposition filed on behalf of Purchasers filed by AmerisourceBergen Corporation, AmerisourceBergen Drug Corporation, CESAR CASTILLO, INC., individually and on behalf of all those similarly situated, Cardinal Health P.R. 120, Inc., Cardinal Health, Inc., FWK Holdings, LLC, H.D. Smith, LLC, KPH Healthcare Services, Inc., MLI RX, LLC, McKesson Corporation, Meijer Distribution, Inc., Meijer, Inc., Rochester Drug Cooperative, Inc., on behalf of itself and all others similarly situated, SUPERVALU, Inc., Smith Medical Partners, LLC, The Harvard Drug Group, L.L.C., Valley Wholesale Drug Company, LLC, Wegmans Food Markets, Inc.. (Monroe, William)
-
Response | Filed: January 30, 2023 | Entered: January 30, 2023 In Re: Zetia (Ezetimibe) Antitrust Litigation
Anti-Trust | Virginia Eastern
Memorandum in Opposition
Memorandum in Opposition re 1855 MOTION in Limine No. 22 to Preclude Drs. McGuire and Leffler from Opining, and Plaintiffs from Arguing, that their Valuations of the Challenged Provision Accounted for Merck's Right to Launch a Second Branded Ezetimibe Product (on behalf of Me Memorandum in Opposition filed on behalf of Purchasers filed by AmerisourceBergen Corporation, AmerisourceBergen Drug Corporation, CESAR CASTILLO, INC., individually and on behalf of all those similarly situated, Cardinal Health P.R. 120, Inc., Cardinal Health, Inc., FWK Holdings, LLC, H.D. Smith, LLC, KPH Healthcare Services, Inc., MLI RX, LLC, McKesson Corporation, Meijer Distribution, Inc., Meijer, Inc., Rochester Drug Cooperative, Inc., on behalf of itself and all others similarly situated, SUPERVALU, Inc., Smith Medical Partners, LLC, The Harvard Drug Group, L.L.C., Valley Wholesale Drug Company, LLC, Wegmans Food Markets, Inc.. (Monroe, William)
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Archive of over 450,000 articles
- Database of over 2.1 million cases
- 62,000+ organization-specific pages.
- Daily and real-time news and case alerts on organizations, industries, and customized search queries.
- Significant legal events involving law firms, companies, industries, and government agencies.
- Learn more
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login